Research-grade cranberry
This article was originally published in The Tan Sheet
Executive Summary
McKesson's BioServices division has inked a five-year, $2.8 mil. contract with NCCAM to develop research-grade cranberry products for center-funded basic, clinical research on role of cranberry "in the prevention and treatment of urinary tract infections" and other applications, firm says Oct. 23. McKesson will subcontract with Ocean Spray, which will donate "research product and analytical research services." Test batches and prototypes are being developed now for a cranberry capsule, placebo capsule, standardized juice cocktail similar to firm's flagship beverage and placebo beverage that replicates cocktail flavor without cranberry. McKesson's responsibilities will include labeling, storage, distribution and delivery of products. Actual product for use in research expected in Fall 2003...